Posted in | News | Nanoenergy | Nanofabrication

BESSTECH Receives $250,000 ENYA Investment to Accelerate Commercialization of Lithium-Ion Battery Technology

BESSTECH Announces $250K Investment from Eastern New York Angels Funding will accelerate commercialization of BESSTECH’s innovative lithium-ion battery electrode technology and enable hiring of key personnel

BESSTECH LLC, a developer of innovative components that improve lithium-ion battery performance and storage, today announced that it has received a $250,000 investment from the Eastern New York Angels (ENYA) to accelerate commercialization of its technology and further build its workforce in New York State.

The investment by ENYA will enable BESSTECH to expand its manufacturing partnerships to further advance market introduction of its low-cost, high-performance silicon-based anodes for lithium-ion battery applications. These new capabilities will also allow BESSTECH to establish additional development programs with its customers to drive adoption and integration of its technology, which is exclusively licensed from SUNY Polytechnic Institute’s Colleges of Nanoscale Science and Engineering (CNSE).

And, the funding will assist BESSTECH in growing its staff, with up to 5 new positions, including a chief technology officer, engineer and technicians, to be filled.

“We are grateful to the Eastern New York Angels, and co-managers Joe Richardson and Dick Frederick, for providing this important financial support, which will play a critical role in jump-starting the introduction of BESSTECH’s innovative technology to the battery market,” said Fernando Gómez-Baquero, CEO of BESSTECH LLC. “These resources will enable us to accelerate commercialization and manufacturing of our lithium-ion battery technology, and continue to build our team, positioning us to capitalize on a rapidly expanding marketplace.”

“This investment in BESSTECH is a further vote of confidence in both the technology and the team behind it,” said ENYA Co-Manager Joseph Richardson. “The need for BESSTECH’s novel technology is both significant and growing, with an increasingly mobile, on-demand society that requires improved battery performance to power more and more electronic devices. We look forward to seeing further growth as BESSTECH takes advantage of this opportunity.”
BESSTECH’s anode technology can produce lighter lithium-ion batteries that charge faster – with charging rates as low as 6 minutes – have longer times between charging, and offer increased lifetimes of more than 1,000 cycles.

With the funding provided by ENYA, BESSTECH has now raised more than $1.3 million from public and private sources and is on track to reach its investment target for 2015.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    BESSTECH - Battery Energy Storage Solutions. (2019, February 11). BESSTECH Receives $250,000 ENYA Investment to Accelerate Commercialization of Lithium-Ion Battery Technology. AZoNano. Retrieved on November 05, 2024 from https://www.azonano.com/news.aspx?newsID=32751.

  • MLA

    BESSTECH - Battery Energy Storage Solutions. "BESSTECH Receives $250,000 ENYA Investment to Accelerate Commercialization of Lithium-Ion Battery Technology". AZoNano. 05 November 2024. <https://www.azonano.com/news.aspx?newsID=32751>.

  • Chicago

    BESSTECH - Battery Energy Storage Solutions. "BESSTECH Receives $250,000 ENYA Investment to Accelerate Commercialization of Lithium-Ion Battery Technology". AZoNano. https://www.azonano.com/news.aspx?newsID=32751. (accessed November 05, 2024).

  • Harvard

    BESSTECH - Battery Energy Storage Solutions. 2019. BESSTECH Receives $250,000 ENYA Investment to Accelerate Commercialization of Lithium-Ion Battery Technology. AZoNano, viewed 05 November 2024, https://www.azonano.com/news.aspx?newsID=32751.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.